Molecular architecture of G protein‐coupled receptors

This review of the current literature on mutations in G protein‐coupled receptors (GPCRs) of the rhodopsin‐related family intends to draw inferences from amino acid sequences for single receptors and multiple sequence alignments with regard to the molecular architecture of this class of receptors. For this purpose a comprehensive list of mutations within the transmembrane helical regions (TMs; over 390 mutations from 38 different receptor subtypes) and their effects on function was compiled, and an alignment of known GPCR sequences (over 150 separate sequences) was made. Regions most prominently involved in ligand binding are located in TMs 3, 5, 6, and 7. Position 3.32 in TM3 is occupied by a D in all biogenic amine receptors (sequence conservation) but may be occupied by uncharged residues in other receptors while its role in ligand binding is analogous (function conservation). TMs 5, 6, and 7 display considerable sequence conservation throughout the majority of GPCRs investigated, but not necessarily at those positions involved in ligand binding. However, considerable function conservation is observed for positions 5.42 (frequently hydrophilic), 5.46 (small amino acids required for agonist binding to “small ligand” receptors), 6.52 and 7.39 (high variability), and 7.43 (frequently aromatic). A general conclusion of this review is that there is overwhelming conservation of structure‐function correlates among GPCRs. Thus, it is now possible to cross‐correlate the results of mutagenesis studies between CPCRs of different subfamilies, and to use those results to predict the function of specific residues in new GPCR sequences. © 1996 Wiley‐Liss, Inc.

[1]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.

[2]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Ascoli,et al.  Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. , 1993, Molecular endocrinology.

[4]  R. Mark,et al.  Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. , 1992, The Journal of biological chemistry.

[5]  G von Heijne,et al.  Membrane proteins: from sequence to structure. , 1990, Protein engineering.

[6]  B. Roth,et al.  A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. , 1993, Molecular pharmacology.

[7]  J. Baldwin The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[8]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[9]  C. M. Chen,et al.  The role of the WSXWS equivalent motif in growth hormone receptor function. , 1994, The Journal of biological chemistry.

[10]  M. Duggan,et al.  Orphan seven transmembrane domain receptors: reversing pharmacology. , 1994, Trends in pharmacological sciences.

[11]  T. Endo,et al.  Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding. , 1994, Life sciences.

[12]  H. Lester,et al.  cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Egloff,et al.  Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling , 1992, Journal of cellular biochemistry.

[14]  M. Saji,et al.  A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.

[15]  C. Fraser,et al.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.

[16]  J. Linden,et al.  Molecular cloning and characterization of the human A3 adenosine receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[18]  J. Schwartz,et al.  Cloning and tissue expression of a rat histamine H2-receptor gene. , 1991, Biochemical and Biophysical Research Communications - BBRC.

[19]  H. G. Khorana,et al.  Light-stable rhodopsin. II. An opsin mutant (TRP-265----Phe) and a retinal analog with a nonisomerizable 11-cis configuration form a photostable chromophore. , 1992, The Journal of biological chemistry.

[20]  Jonathan A Javitch,et al.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.

[21]  J. Wess,et al.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition. , 1996, Molecular pharmacology.

[22]  P. Albert Molecular biology of the 5-HT1A receptor: Low-stringency cloning and eukaryotic expression , 1992, Journal of Chemical Neuroanatomy.

[23]  L. Hunyady,et al.  Critical Role of a Conserved Intramembrane Tyrosine Residue in Angiotensin II Receptor Activation (*) , 1995, The Journal of Biological Chemistry.

[24]  S. Chaki,et al.  Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.

[25]  P. Schofield,et al.  A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. , 1994, The Journal of biological chemistry.

[26]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[27]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[28]  R. Straub,et al.  Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Nakai,et al.  Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling , 1988, FEBS letters.

[30]  G. FitzGerald,et al.  Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. , 1993, Molecular pharmacology.

[31]  R. Osman,et al.  Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. , 1995, Molecular pharmacology.

[32]  P. Corvol,et al.  Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Ashkenazi,et al.  Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors. , 1987, The EMBO journal.

[34]  J. Nathans,et al.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin , 1983, Cell.

[35]  C. Strader,et al.  Mapping the ligand binding site of the NK-1 receptor , 1993, Regulatory Peptides.

[36]  J. Lowe,et al.  Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected]. , 1994, The Journal of biological chemistry.

[37]  S. Vishveshwara,et al.  Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.

[38]  D. Oxender,et al.  Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968. , 1994, Biochemical and biophysical research communications.

[39]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[40]  B. Roth,et al.  Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors. , 1992, Molecular pharmacology.

[41]  T. Satoh,et al.  Analysis of the TSH receptor gene structure in various thyroid disorders: DNA from thyroid adenomas can have large insertions or deletions. , 1992, Thyroid : official journal of the American Thyroid Association.

[42]  D. Bichet,et al.  Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. , 1994, Cellular and molecular biology.

[43]  D. Oprian,et al.  Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. , 1992, Biochemistry.

[44]  Takao Shimizu,et al.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.

[45]  K. Jacobson,et al.  Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists. , 1994, The Journal of biological chemistry.

[46]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[47]  K. Livak,et al.  Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Wess,et al.  Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.

[49]  R. Paschke,et al.  Importance of the extracellular domain of the human thyrotrophin receptor for activation of cyclic AMP production. , 1994, Journal of Molecular Endocrinology.

[50]  J. Lowe,et al.  Molecular basis for the species selectivity of the substance P antagonist CP-96,345. , 1993, The Journal of biological chemistry.

[51]  T L Blundell,et al.  The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.

[52]  R. Alexander,et al.  Molecular cloning of AT1 angiotensin receptors. , 1992, American journal of hypertension.

[53]  M. Mishina,et al.  Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor , 1986, Nature.

[54]  S. Kaushal,et al.  Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. , 1994, Biochemistry.

[55]  C. Strader,et al.  Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. , 1992, The Journal of biological chemistry.

[56]  J. Harrison,et al.  cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors , 1994, Neuroscience Letters.

[57]  S. Narumiya,et al.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. , 1994, The Journal of clinical investigation.

[58]  J. Hénichart,et al.  Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells. , 1995, Journal of receptor and signal transduction research.

[59]  M. Caron,et al.  An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins , 1987, Nature.

[60]  B. Fredholm Purinoceptors in the nervous system. , 1995, Pharmacology & toxicology.

[61]  K. Jakobs,et al.  Deletion analysis of the m4 muscarinic acetylcholine receptor. Molecular determinants for activation of but not coupling to the Gi guanine-nucleotide-binding regulatory protein regulate receptor internalization. , 1994, European journal of biochemistry.

[62]  S. Coughlin Expanding horizons for receptors coupled to G proteins: diversity and disease. , 1994, Current opinion in cell biology.

[63]  J. Venter,et al.  Cloning, localization, and permanent expression of a Drosophila octopamine receptor , 1990, Neuron.

[64]  C. Slaughter,et al.  The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains. , 1988, The Journal of biological chemistry.

[65]  S Schiffmann,et al.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.

[66]  D. Kunz,et al.  The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. , 1992, The Journal of biological chemistry.

[67]  K. Arai,et al.  GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction , 1987, Cell.

[68]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[69]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[70]  M. Freeman,et al.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. , 1991, Science.

[71]  R. Osman,et al.  A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. , 1994, The Journal of biological chemistry.

[72]  M. Belfort,et al.  Mechanisms of Intron Mobility (*) , 1995, The Journal of Biological Chemistry.

[73]  K. Lynch,et al.  RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. Diviani,et al.  Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor. , 1994, The Journal of biological chemistry.

[75]  I Simon,et al.  New alignment strategy for transmembrane proteins. , 1994, Journal of molecular biology.

[76]  N. Birdsall Cloning and structure-function of the H2 histamine receptor. , 1991, Trends in pharmacological sciences.

[77]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[78]  K. Jacobson,et al.  Modelling the P2Y purinoceptor using rhodopsin as template. , 1995, Drug design and discovery.

[79]  J. T. Turner,et al.  Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.

[80]  N. Bunnett,et al.  Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[81]  M. Caron,et al.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.

[82]  A. Kopin,et al.  A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists , 1993, Nature.

[83]  Y. Fukada,et al.  What makes red visual pigments red? A resonance Raman microprobe study of retinal chromophore structure in iodopsin. , 1994, Biochemistry.

[84]  R. Paschke,et al.  Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. , 1994, The Journal of clinical endocrinology and metabolism.

[85]  M. Caron,et al.  Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.

[86]  J. Wess,et al.  Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. , 1994, The Journal of biological chemistry.

[87]  E. B. Hart,et al.  COMPARATIVE EFFICIENCY FOR GROWTH OF THE TOTAL NITROGEN FROM ALFALFA HAY AND CORN GRAIN , 1912 .

[88]  B. Kobilka,et al.  Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. , 1993, Molecular pharmacology.

[89]  C. Strader,et al.  Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345 , 1993, Nature.

[90]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[91]  Hong Wang,et al.  Site-directed anti-peptide antibodies define the topography of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[92]  Adriaan P. IJzerman,et al.  Relative binding orientations of adenosine A1 receptor ligands — A test case for Distributed Multipole Analysis in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..

[93]  M. Caron,et al.  High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains. , 1994, Molecular pharmacology.

[94]  S. Loche,et al.  Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. , 1994, Human molecular genetics.

[95]  J. Venter,et al.  Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[96]  C. Strader,et al.  Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[97]  E. Sausville,et al.  Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. , 1991, The Journal of biological chemistry.

[98]  E. Hulme,et al.  Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. , 1990, The Journal of biological chemistry.

[99]  A. Tucker,et al.  A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. , 1994, The Journal of biological chemistry.

[100]  J. Krause,et al.  The roles of the putative third cytoplasmic loop and cytoplasmic carboxyl tail of NK-1 and NK-2 receptors in agonist stimulated second messenger responses in stably transfected CHO cells , 1993, Regulatory Peptides.

[101]  R. H. Hilderman,et al.  Identification of a serine protease which activates the mouse heart adenosine 5',5"',P1,P4-tetraphosphate receptor. , 1993, Biochemistry.

[102]  H. Ladinsky,et al.  The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. , 1991, Biochemical and biophysical research communications.

[103]  H. Akil,et al.  Cloning and characterization of a pharmacologically distinct A1 adenosine receptor from guinea pig brain. , 1994, Brain research. Molecular brain research.

[104]  M. Mortrud,et al.  Cloning and Functional Characterization of a Family of Receptors for the Melanotropic Peptides , 1993, Annals of the New York Academy of Sciences.

[105]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[106]  C. Azuma,et al.  Molecular cloning of a human oxytocin receptor , 1993, Regulatory Peptides.

[107]  T. Bonner,et al.  Identification of a family of muscarinic acetylcholine receptor genes. , 1987, Science.

[108]  H. Khorana,et al.  Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. , 1992, The Journal of biological chemistry.

[109]  W. Sadee,et al.  Serine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. , 1993, The Journal of biological chemistry.

[110]  Marina Cocchi,et al.  Quantitative structure-affinity/selectivity relationship analysis on three-dimensional models of the complexes between the ETA and ETB receptors and C-terminal endothelin hexapeptide antagonists , 1995 .

[111]  E. Kieff,et al.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.

[112]  J. Linden Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. , 1994, Trends in pharmacological sciences.

[113]  Gunnar von Heijne,et al.  Proline kinks in transmembrane α-helices☆ , 1991 .

[114]  J. Wess,et al.  Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants. , 1992, The Journal of biological chemistry.

[115]  D. Julius,et al.  Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[116]  K. Neve,et al.  Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. , 1994, The Journal of biological chemistry.

[117]  J. Nielsen,et al.  Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.

[119]  S. Kosugi,et al.  The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction , 1994, FEBS letters.

[120]  J. Wess,et al.  Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[121]  M. Hanley,et al.  Attenuation of agonist‐induced desensitization of the rat substance P receptor by progressive truncation of the C‐terminus , 1994, FEBS letters.

[122]  H. Matsubara,et al.  Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. , 1993, Biochemical and biophysical research communications.

[123]  S. Souza,et al.  A 40-Amino Acid Segment of the Growth Hormone Receptor Cytoplasmic Domain Is Essential for GH-induced Tyrosine-phosphorylated Cytosolic Proteins (*) , 1995, The Journal of Biological Chemistry.

[124]  A. Rashtchian,et al.  Novel methods for cloning and engineering genes using the polymerase chain reaction. , 1995, Current opinion in biotechnology.

[125]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[126]  W. Greenlee,et al.  Non-peptide Angiotensin Agonist , 1995, The Journal of Biological Chemistry.

[127]  J. Richardson,et al.  Amino acid preferences for specific locations at the ends of alpha helices. , 1988, Science.

[128]  C. Fraser,et al.  Cross-talk between m1 muscarinic acetylcholine and beta 2-adrenergic receptors. cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation. , 1993, The Journal of biological chemistry.

[129]  S. Chaki,et al.  Cloning, expression and regulation of angiotensin II receptors. , 1992, Advances in experimental medicine and biology.

[130]  J. Wess,et al.  Functional role of proline and tryptophan residues highly conserved among G protein‐coupled receptors studied by mutational analysis of the m3 muscarinic receptor. , 1993, The EMBO journal.

[131]  K. Fahmy,et al.  Photoactivated state of rhodopsin and how it can form. , 1995, Biophysical chemistry.

[132]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[133]  J. Wess,et al.  Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.

[134]  S. Nakanishi,et al.  Molecular characterization of a functional cDNA for rat substance P receptor. , 1989, The Journal of biological chemistry.

[135]  J. Wess,et al.  Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. , 1994, The Journal of biological chemistry.

[136]  R. Leurs,et al.  Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. , 1994, Biochemical and biophysical research communications.

[137]  Soma Das,et al.  Mutations in the V2 vasopressin receptor gene are associated with X–linked nephrogenic diabetes insipidus , 1992, Nature Genetics.

[138]  J. Baldwin,et al.  Structure and function of receptors coupled to G proteins. , 1994, Current opinion in cell biology.

[139]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[140]  J. T. Turner,et al.  Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[141]  H. Kao,et al.  Site‐directed mutagenesis of a single residue changes the binding properties of the serotonin 5‐HT2 receptor from a human to a rat pharmacology , 1992, FEBS letters.

[142]  T. Reisine,et al.  Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. , 1993, Molecular pharmacology.

[143]  C. Strader,et al.  Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. , 1994, The Journal of biological chemistry.

[144]  R. Jensen,et al.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[145]  T. Endo,et al.  Point mutations in the thyrotropin receptor in human thyroid tumors. , 1995, Thyroid : official journal of the American Thyroid Association.

[146]  D. Oprian,et al.  Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness , 1993, Nature Genetics.

[147]  K. Jacobson,et al.  Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor. , 1992, Drug design and discovery.

[148]  T. Sakmar,et al.  Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition. , 1993, The Journal of biological chemistry.

[149]  H Hayashi,et al.  Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.

[150]  E. Ross,et al.  Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins. , 1994, The Journal of biological chemistry.

[151]  R. Dixon,et al.  Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. , 1987, Nucleic acids research.

[152]  T. Dryja,et al.  Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[153]  R. Mackenzie,et al.  A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2‐selective agonist , 1993, FEBS letters.

[154]  J Hoflack,et al.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.

[155]  T. Minegishi,et al.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.

[156]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[157]  M. Uhler,et al.  Molecular cloning of a gene encoding the histamine H2 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[158]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[159]  E. Prossnitz,et al.  Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. , 1991, Biochemical and biophysical research communications.

[160]  P. Devreotes,et al.  A chemoattractant receptor controls development in Dictyostelium discoideum. , 1988, Science.

[161]  K. Jacobson,et al.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. , 1992, The Journal of biological chemistry.

[162]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[163]  S. Green,et al.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. , 1995, The Journal of clinical investigation.

[164]  B. Kobilka,et al.  A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.

[165]  A. Shenker,et al.  Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor , 1994, FEBS letters.

[166]  L. Blomberg,et al.  Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[167]  K. Page,et al.  The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. , 1995, European journal of pharmacology.

[168]  J Hoflack,et al.  Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. , 1995, The EMBO journal.

[169]  T. Endo,et al.  Desensitization and internalization of a thyrotrophin receptor lacking the cytoplasmic carboxy-terminal region. , 1994, Journal of molecular endocrinology.

[170]  D. Cerretti,et al.  Molecular characterization of the interleukin-8 receptor. , 1991, Biochemical and biophysical research communications.

[171]  D. Donnelly,et al.  The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. , 1996, The Journal of Biological Chemistry.

[172]  N. Pollock,et al.  Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. , 1992, The Journal of biological chemistry.

[173]  Y. Horio,et al.  Expression cloning of a cDNA encoding the bovine histamine H1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[174]  T. Schwartz,et al.  Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. , 1994, The Journal of biological chemistry.

[175]  T. Ji,et al.  Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. , 1991, The Journal of biological chemistry.

[176]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[177]  G. Stiles,et al.  Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[178]  Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors. , 1994, Molecular pharmacology.

[179]  M. Brann,et al.  Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. , 1993, Molecular pharmacology.

[180]  M. Caron,et al.  The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor , 1988, Nature.

[181]  D. Oprian,et al.  Effect of carboxylic acid side chains on the absorption maximum of visual pigments. , 1989, Science.

[182]  D. Donnelly,et al.  Seven-helix receptors: structure and modelling , 1994 .

[183]  G. Mcallister,et al.  Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells , 1993, FEBS letters.

[184]  M. Birnbaumer,et al.  Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. , 1993, The Journal of biological chemistry.

[185]  Y. Sugimoto,et al.  Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. , 1993, The Journal of biological chemistry.

[186]  M. Gregory,et al.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. , 1993, The Journal of clinical investigation.

[187]  B. Kobilka,et al.  Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.

[188]  T. Sakmar,et al.  Introduction of hydroxyl-bearing amino acids causes bathochromic spectral shifts in rhodopsin. Amino acid substitutions responsible for red-green color pigment spectral tuning. , 1992, The Journal of biological chemistry.

[189]  T. Sakmar,et al.  Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. , 1993, The Journal of biological chemistry.

[190]  Gert Vriend,et al.  A common motif in G-protein-coupled seven transmembrane helix receptors , 1993, J. Comput. Aided Mol. Des..

[191]  H. Khorana,et al.  Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[192]  M. Parmentier,et al.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. , 1991, The EMBO journal.

[193]  Kolakowski Lf GCRDB: A G-PROTEIN-COUPLED RECEPTOR DATABASE , 1994 .

[194]  E. Mutschler,et al.  Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. , 1994, The Journal of biological chemistry.

[195]  Yoshihisa Inoue,et al.  Mutagenesis and the Molecular Modeling of the Rat Angiotensin II Receptor (AT1) (*) , 1995, The Journal of Biological Chemistry.

[196]  W. Greenlee,et al.  Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.

[197]  C. Strader,et al.  The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. , 1994, The Journal of biological chemistry.

[198]  G. Baldwin,et al.  The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. , 1994, Biochemical and biophysical research communications.

[199]  T. Schwartz,et al.  Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.

[200]  R. Lefkowitz,et al.  Constitutively active mutants of the alpha 2-adrenergic receptor. , 1993, The Journal of biological chemistry.

[201]  H. Tai,et al.  Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. , 1995, The Biochemical journal.

[202]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[203]  K. Jarnagin,et al.  Expression cloning of a rat B2 bradykinin receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[204]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[205]  R. Shapiro,et al.  A deletion mutation in the third cytoplasmic loop of the mouse m1 muscarinic acetylcholine receptor unmasks cryptic G-protein binding sites. , 1993, The Journal of biological chemistry.

[206]  D. Westfall,et al.  Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. , 1994, Pharmacological reviews.

[207]  J. Nathans,et al.  Histidine residues regulate the transition of photoexcited rhodopsin to its active conformation, metarhodopsin II , 1992, Neuron.

[208]  M. Brann,et al.  Structure-Function of Muscarinic Receptor Coupling to G Proteins , 1995, The Journal of Biological Chemistry.

[209]  Brian K. Kobilka,et al.  Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.

[210]  Yi-Jun Guo,et al.  Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.

[211]  R A Gibbs,et al.  Multiplex PCR: advantages, development, and applications. , 1994, PCR methods and applications.

[212]  H. Lester,et al.  The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation study , 1992, FEBS letters.

[213]  J. Bockaert,et al.  The metabotropic glutamate receptors: their second intracellular loop plays a critical role in the G-protein coupling specificity. , 1995, Biochemical Society transactions.

[214]  J. Millán,et al.  Gly114Asp mutation of rhodopsin in autosomal dominant retinitis pigmentosa. , 1995, Molecular and Cellular Probes.

[215]  B. V. van Oost,et al.  Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. , 1994, Kidney international.

[216]  B. Ozenberger,et al.  A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. , 1995, Molecular pharmacology.

[217]  J. Novotný,et al.  Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. , 1994, The Journal of biological chemistry.

[218]  L. Musgrove,et al.  Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. , 1992, Biochemical and biophysical research communications.

[219]  T. Schwartz,et al.  Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. , 1993, The Journal of biological chemistry.

[220]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[221]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[222]  M. Ascoli,et al.  The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. , 1993, Molecular endocrinology.

[223]  E. Borrelli,et al.  Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.

[224]  E M Brown,et al.  Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs (*) , 1995, The Journal of Biological Chemistry.

[225]  H. G. Khorana,et al.  Palmitoylation of bovine opsin and its cysteine mutants in COS cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[226]  S. Nakanishi,et al.  Sequence and expression of a metabotropic glutamate receptor , 1991, Nature.

[227]  G. Burnstock,et al.  Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.

[228]  T. Gallaher,et al.  Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. , 1993, Molecular pharmacology.

[229]  H. Khorana,et al.  Structure and function in rhodopsin. Separation and characterization of the correctly folded and misfolded opsins produced on expression of an opsin mutant gene containing only the native intradiscal cysteine codons. , 1995, Biochemistry.

[230]  C. Fraser,et al.  Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.

[231]  T. Schwartz,et al.  Conserved HisVI‐17 of the NK‐1 receptor is involved in binding of non‐peptide antagonists but not substance P , 1993, FEBS letters.

[232]  S. Nakanishi,et al.  Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor , 1992, Regulatory Peptides.

[233]  B. O'dowd,et al.  A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors , 1992, Nature.

[234]  E. Emini,et al.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide , 1985, Journal of virology.

[235]  G. Dorn,et al.  Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[236]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[237]  W. Meyerhof,et al.  Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions. , 1991, DNA and cell biology.

[238]  T. Schwartz,et al.  The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. , 1994, Molecular pharmacology.

[239]  STE2 protein of Saccharomyces kluyveri is a member of the rhodopsin/beta-adrenergic receptor family and is responsible for recognition of the peptide ligand alpha factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[240]  S. Fuchs,et al.  In vitro translation of D2 dopamine receptors and their chimaeras: analysis by subtype-specific antibodies. , 1994, Biochemical and biophysical research communications.

[241]  R. Osman,et al.  Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. , 1994, The Journal of biological chemistry.

[242]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[243]  B. Kobilka,et al.  Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. , 1994, The Journal of biological chemistry.

[244]  C. Strader,et al.  Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.

[245]  R. Lefkowitz,et al.  Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[246]  C. Strader,et al.  Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. , 1992, The Journal of biological chemistry.

[247]  C. A. Guyer,et al.  An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium. , 1990, The Journal of biological chemistry.

[248]  T. Schwartz,et al.  Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.

[249]  M. Caron,et al.  Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.

[250]  R. Bennett,et al.  Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. , 1994, American journal of human genetics.

[251]  J. Navarro,et al.  Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. , 1990, The Journal of biological chemistry.

[252]  A. Shenker,et al.  Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.

[253]  S. Liggett,et al.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[254]  C. Fraser Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. , 1989, The Journal of biological chemistry.

[255]  M. Brownstein,et al.  Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors , 1993, Regulatory Peptides.

[256]  H. Khorana,et al.  Resonance Raman microprobe spectroscopy of rhodopsin mutants: effect of substitutions in the third transmembrane helix. , 1992, Biochemistry.

[257]  M. Birnbaumer,et al.  An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system. , 1994, Molecular endocrinology.

[258]  G. Barsh,et al.  Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.

[259]  H. Khorana,et al.  Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[260]  S. Yokoyama,et al.  Rhodopsin from the fish, Astyanax: role of tyrosine 261 in the red shift. , 1995, Investigative ophthalmology & visual science.

[261]  J. Venter,et al.  Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation. , 1988, The Journal of biological chemistry.

[262]  C. Strader,et al.  Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.

[263]  R. Osman,et al.  Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. , 1992, The Journal of biological chemistry.

[264]  J. Nathans,et al.  Rhodopsin mutation proline347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347. , 1995, Human molecular genetics.

[265]  S. Sealfon,et al.  Molecular function of the gonadotropin-releasing hormone receptor: insights from site-directed mutagenesis , 1994, Molecular and Cellular Endocrinology.

[266]  S. Snyder,et al.  Cloning and expression of a rat somatostatin receptor enriched in brain. , 1992, The Journal of biological chemistry.

[267]  N. Arnheim,et al.  The polymerase chain reaction. , 1989, Trends in genetics : TIG.

[268]  M. Gershengorn Thyrotropin-releasing hormone receptor: cloning and regulation of its expression. , 1993, Recent progress in hormone research.

[269]  E. Parker,et al.  A Single Amino Acid Difference Accounts for the Pharmacological Distinctions Between the Rat and Human 5‐Hydroxytryptamine1B Receptors , 1993, Journal of neurochemistry.

[270]  Paul H. J. Nederkoorn,et al.  Modelling and mutation studies on the histamine H1-receptor agonist binding site reveal different binding modes for H1-agonists: Asp116 (TM3) has a constitutive role in receptor stimulation , 1995, J. Comput. Aided Mol. Des..

[271]  C. Strader,et al.  A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. , 1989, The Journal of biological chemistry.

[272]  M. Caron,et al.  Cloning of the cDNA and genes for the hamster and human beta 2-adrenergic receptors. , 1988, Journal of receptor research.

[273]  P. Goldman-Rakic,et al.  Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[274]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[275]  P. Sieving,et al.  Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa. , 1995, Ophthalmology.

[276]  E. Liu,et al.  Aspartate mutation distinguishes ETA but not ETB receptor subtype‐selective ligand binding while abolishing phospholipase C activation in both receptors , 1995, FEBS letters.

[277]  M. Houslay G‐protein linked receptors: a family probed by molecular cloning and mutagenesis procedures , 1992, Clinical endocrinology.

[278]  Mark Froimowitz,et al.  Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. , 1994, Journal of medicinal chemistry.

[279]  H. Weinstein,et al.  Polarity conserved positions in transmembrane domains of G‐protein coupled receptors and bacteriorhodopsin , 1994, FEBS letters.

[280]  K. Neve,et al.  Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. , 1991, Molecular pharmacology.

[281]  Gebhard F. X. Schertler,et al.  Projection structure of rhodopsin , 1993, Nature.

[282]  J. Wess,et al.  Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors. , 1992, Molecular pharmacology.

[283]  C. Barberis,et al.  Expression cloning of the human V2 vasopressin receptor , 1993, Regulatory Peptides.

[284]  K. Jacobson,et al.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. , 1994, The Journal of biological chemistry.

[285]  J. Pouysségur,et al.  Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.

[286]  L. E. Bockstahler Overview of international PCR standardization efforts. , 1994, PCR methods and applications.

[287]  R. Jensen,et al.  The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. , 1993, The Journal of biological chemistry.

[288]  C. Broger,et al.  Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. , 1995, European journal of biochemistry.

[289]  K. Jacobson,et al.  Adenosine A1 and A2 receptors: Structure–function relationships , 1992, Medicinal research reviews.

[290]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[291]  G Vassart,et al.  Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.

[292]  P. Prusis,et al.  A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. , 1995, Biochemical and biophysical research communications.

[293]  J. Wess,et al.  Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover , 1989, FEBS letters.

[294]  D. Oprian,et al.  Constitutively active mutants of rhodopsin , 1992, Neuron.

[295]  H. Akil,et al.  Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.

[296]  A. Surprenant,et al.  A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents. , 1992, Science.